[{"Physician_Profile_ID": "260479", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "8222.04", "Date_of_Payment": "09/16/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "31509529", "Name_of_Associated_Covered_Drug_or_Biological1": "ADVAIR DISKUS", "Name_of_Associated_Covered_Drug_or_Biological2": "SERETIDE ACCUHALER", "Name_of_Study": "A 26 WEEK SAFETY STUDY OF INHALED FLUTICASONE PROPIONATE  SALMETEROL COMBINATION VERSUS INHALED FLUTICASONE PROPIONATE IN THE TREATMENT OF ADOLESCENT AND ADULT SUBJECTS WITH PERSISTENT ASTHMA", "Research_Information_Link": "", "Context_of_Research": ""}, {"Physician_Profile_ID": "260479", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Sanofi Pasteur Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000299", "Total_Amount_of_Payment_USDollars": "2015.33", "Date_of_Payment": "09/24/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "182047028", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "Fluzone", "Research_Information_Link": "", "Context_of_Research": ""}, {"Physician_Profile_ID": "260479", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Sanofi Pasteur Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000299", "Total_Amount_of_Payment_USDollars": "1967.44", "Date_of_Payment": "12/31/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "21688729", "Name_of_Associated_Covered_Drug_or_Biological1": "FLUZONE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "Annual Fluzone Adult Study GRC52", "Research_Information_Link": "", "Context_of_Research": ""}, {"Physician_Profile_ID": "260479", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Sanofi Pasteur Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000299", "Total_Amount_of_Payment_USDollars": "1967.44", "Date_of_Payment": "12/31/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "21688730", "Name_of_Associated_Covered_Drug_or_Biological1": "FLUZONE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "Annual Fluzone Adult Study GRC52", "Research_Information_Link": "", "Context_of_Research": ""}, {"Physician_Profile_ID": "260479", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "GlaxoSmithKline, LLC.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "NC", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005449", "Total_Amount_of_Payment_USDollars": "1653.33", "Date_of_Payment": "10/28/2013", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "31509531", "Name_of_Associated_Covered_Drug_or_Biological1": "ADVAIR DISKUS", "Name_of_Associated_Covered_Drug_or_Biological2": "SERETIDE ACCUHALER", "Name_of_Study": "A 26 WEEK SAFETY STUDY OF INHALED FLUTICASONE PROPIONATE  SALMETEROL COMBINATION VERSUS INHALED FLUTICASONE PROPIONATE IN THE TREATMENT OF ADOLESCENT AND ADULT SUBJECTS WITH PERSISTENT ASTHMA", "Research_Information_Link": "", "Context_of_Research": ""}, {"Physician_Profile_ID": "260479", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Sanofi Pasteur Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000299", "Total_Amount_of_Payment_USDollars": "690.76", "Date_of_Payment": "09/24/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "182047026", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "Fluzone", "Research_Information_Link": "", "Context_of_Research": ""}, {"Physician_Profile_ID": "260479", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Sanofi Pasteur Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000299", "Total_Amount_of_Payment_USDollars": "461.67", "Date_of_Payment": "12/31/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "21688706", "Name_of_Associated_Covered_Drug_or_Biological1": "FLUZONE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "Annual Fluzone Adult Study GRC52", "Research_Information_Link": "", "Context_of_Research": ""}, {"Physician_Profile_ID": "260479", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Sanofi Pasteur Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000299", "Total_Amount_of_Payment_USDollars": "461.67", "Date_of_Payment": "12/31/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "21688705", "Name_of_Associated_Covered_Drug_or_Biological1": "FLUZONE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "Annual Fluzone Adult Study GRC52", "Research_Information_Link": "", "Context_of_Research": ""}, {"Physician_Profile_ID": "260479", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Sanofi Pasteur Inc.", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "PA", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000000299", "Total_Amount_of_Payment_USDollars": "100.00", "Date_of_Payment": "03/11/2014", "Form_of_Payment_or_Transfer_of_Value": "Cash or cash equivalent", "Record_ID": "182054310", "Name_of_Associated_Covered_Drug_or_Biological1": "", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "Safety and Immunogenicity Among Adults of Fluzone Quadrivalent  Fluzone Intradermal  and Fluzone High-Dose Influenza Virus Vaccines  2014 2015 Formulations", "Research_Information_Link": "", "Context_of_Research": ""}]